Why the study?
Does routine cancer screening with CT imaging improve the detection of clinically significant malignancies in unselected patients with unprovoked VTE?
Does routine cancer screening with CT imaging improve the detection of clinically significant malignancies in unselected patients with unprovoked VTE?
Routine cancer screening with CT imaging in unselected patients with unprovoked VTE is not justified, as it primarily identifies incidental lesions without detecting unsuspected malignancies.
Low yield of routine CT for occult cancer in unprovoked VTE; leaves open value of selective screening in prospective studies.
In this prospective review of cancer screening in unselected patients with unprovoked venous thromboembolism (VTE) presenting to a large teaching hospital in the Republic of Ireland, we aimed to determine the effects of the implementation of the National Institute for Health and Care Excellence screening policy in a "real-world" population. Within our institution, 64 individuals presented with unprovoked VTE during the study period, of whom 47 underwent a screening computed tomography (CT) scan. Two cases of previously undiagnosed cancer were identified. However, in both cases, the clinical history provided by the affected individuals would have prompted a CT scan regardless of the recommendations of the screening policy. The screening CT scans identified 18 incidental lesions within the cohort, which required further diagnostic studies. None of the additional investigations completed to date have detected any lesion of clinical significance. These findings support the view that cancer screening with CT imaging in unselected individuals with unprovoked VTE is not justified or cost-effective.
No takes yet. Share an insight, caveat, or question.
Barrett et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: